Desh Rakshak

Desh_Rakshak08 Apr 2024

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Desh Rakshak

Desh Rakshak

Pharmaceuticals

Desh_Rakshak08 Apr 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
02-Feb-2024	BC	DESH RAKSHAK AUSHDHALAYA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve 1) To consider and approve the Un	12-Feb-2024
02-Nov-2023	BC	DESH RAKSHAK AUSHDHALAYA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve 1) To consider and approve the	08-Nov-2023
05-Sep-2023	BC	The Register of Members and the share transfer books of the company will remain closed from Saturday, 23rd September, 2023 to Friday, 29th September, 2023 (both days inclusive) for the purpose of 42n	29-Sep-2023
05-Sep-2023	BC	The Register of Members and the share transfer books of the company will remain closed from Saturday, 23rd September, 2023 to Friday, 29th September, 2023 (both days inclusive) for the purpose of 42n	23-Sep-2023
05-Sep-2023	BC	Pursuant to Reg 30 of SEBI (LODR) Reg, 2015, the board of directors in the meeting held on 05.09.2023 subject to the approval of members of the company in the 42nd AGM of the company, considered re a	05-Sep-2023

No Rights has been declared by Desh_Rakshak

Book Closure

Record Date	Split Date	Purpose
12-Feb-2024	-	DESH RAKSHAK AUSHDHALAYA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve 1) To consider and approve the Un
08-Nov-2023	-	DESH RAKSHAK AUSHDHALAYA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve 1) To consider and approve the
29-Sep-2023	-	The Register of Members and the share transfer books of the company will remain closed from Saturday, 23rd September, 2023 to Friday, 29th September, 2023 (both days inclusive) for the purpose of 42n
23-Sep-2023	01 Jan'1900	The Register of Members and the share transfer books of the company will remain closed from Saturday, 23rd September, 2023 to Friday, 29th September, 2023 (both days inclusive) for the purpose of 42n
05-Sep-2023	-	Pursuant to Reg 30 of SEBI (LODR) Reg, 2015, the board of directors in the meeting held on 05.09.2023 subject to the approval of members of the company in the 42nd AGM of the company, considered re a

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Desh Rakshak Aushdhalaya Ltd ₹7.29(0.00/0.00%)	7.29	+0.00	3.24	33.52	7.67	0.36
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1.58	0.84	1.11	1.65	2.47	0.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.58	0.84	1.11	1.65	2.47	0.77
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.00	0.00	0.00	0.00	0.00
Total Income	1.62	0.84	1.11	1.65	2.47	0.77
Total Expenditure	1.27	0.51	0.86	1.20	2.04	0.56
PBIDT	0.36	0.32	0.24	0.45	0.42	0.21
Interest	0.11	0.12	0.05	0.12	0.11	0.10
PBDT	0.24	0.20	0.19	0.34	0.31	0.11
Depreciation	0.11	0.11	0.11	0.14	0.10	0.10
Tax	0.00	0.00	0.00	0.08	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.13	0.09	0.08	0.12	0.21	0.01
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.13	0.09	0.08	0.12	0.21	0.01

EPS (Unit Curr.)	0.30	0.20	0.19	0.26	0.48	0.02
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.48	0.02
Calculated EPS (Unit Curr.)	0.30	0.20	0.19	0.26	0.48	0.02
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.48	0.02
Calculated EPS (Ann.) (Unit Curr.)	1.20	0.81	0.75	1.05	1.91	0.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	1.91	0.09
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.44	4.44	4.44	4.44	4.44	4.44
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.78	38.10	21.62	27.27	17.00	27.27
PBDTM(%)	15.19	23.81	17.12	20.61	12.55	14.29
PATM(%)	8.23	10.71	7.21	7.27	8.50	1.30

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.66	4.66	4.66	4.66	4.66	4.66
Reserves Total	4.47	4.62	4.14	3.72	3.45	3.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	9.13	9.28	8.80	8.38	8.11	7.68
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	4.10	4.31	2.90	2.03	1.23	0.96
Total Debt	4.10	4.31	2.90	2.03	1.23	0.96
Total Liabilities	13.23	13.59	11.70	10.41	9.34	8.64
APPLICATION OF FUNDS :
Gross Block	13.22	12.67	11.08	9.70	8.45	7.84
Less : Accumulated Depreciation	5.15	4.85	4.59	4.32	4.06	3.91
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	8.07	7.82	6.49	5.38	4.39	3.93
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.37	2.37	2.37	2.37	2.37	2.37
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	0.05	0.05	0.12	0.12	0.12
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.81	0.85	0.69	0.79	0.90	1.33
Sundry Debtors	3.64	3.97	3.86	3.07	2.96	2.48
Cash and Bank	0.05	0.23	0.59	0.22	0.16	0.29
Loans and Advances	0.49	0.46	0.34	0.15	0.25	0.12
Total Current Assets	4.99	5.50	5.49	4.23	4.27	4.22
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.33	2.39	2.65	1.65	1.67	1.79
Provisions	0.10	0.12	0.14	0.10	0.13	0.08
Total Current Liabilities	2.43	2.51	2.79	1.76	1.80	1.87
Net Current Assets	2.56	2.99	2.69	2.48	2.47	2.35
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	13.04	13.23	11.60	10.34	9.35	8.77
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.23	0.59	0.22	0.16	0.29
Net Cash from Operating Activities	0.45	0.23	0.84	0.59	-0.55
Net Cash Used In Investing Activities	-0.78	-1.95	-1.26	-1.27	0.42
Net Cash Used In Financing Activities	0.15	1.35	0.80	0.74	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.18	-0.36	0.37	0.06	-0.12
Cash And Cash Equivalents At End Of The Year	0.05	0.23	0.59	0.22	0.16

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

64.28%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

35.72%

**Promoter pledged shareholding 64.28%

About Desh Rakshak Aushdhalaya Ltd

Desh Rakshak Aushdhalaya Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3.24 crores. It has reported a sales of Rs. 1.58 crores and a net profit of Rs. 0.13 crores for the quarter ended December 2018. The company management includes Tosh Kumar Jain, Tosh Kumar Jain,Monika Jain,Arihant Kumar Jain,Mohit Kumar,Sohini Bansal,Shruti Gupta (Desh Rakshak Aushdhalaya Ltd) among others.

Chairman

Tosh Kumar Jain

Registered office

Bhagwant Kuti,Kankhal,Haridwar,Uttarakhand,249408

FAX :91-1334-245866

Background

Incorporation Year1981

Face Value₹10

Market Lot100

How to buy Desh Rakshak shares on nse?

To buy Desh Rakshak shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Desh Rakshak share price today?

The Desh Rakshak shares price on nse is Rs.7.29 today.

What is the market cap of Desh Rakshak shares on BSE ?

The company has a market capitalization of Rs.3.24Cr

What is the PE & PB ratio of Desh Rakshak shares ?

PE is 7.67 and PB is 0.36

What is the 52 Week High and Low of Desh Rakshak shares?

Desh Rakshak stock price high: Rs.7.29 Desh Rakshak stock price low: Rs.5.73